What is PRNAF's health score?

ALTERITY THERAPEUTICS LTD (PRNAF) has a TradeApes health score of 52 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PRNAF's estimated fair value?

Based on our 5-year discounted cash flow model, ALTERITY THERAPEUTICS LTD's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is PRNAF undervalued or overvalued?

Our model currently rates PRNAF as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for PRNAF... Refresh in a moment for the full analysis.

ALTERITY THERAPEUTICS LTD (PRNAF)

Healthcare Fair Value High mixed

Updated: 2026-04-21

TradeApes Score

hold

Financial Strength

45 Mixed

Operating Trend

50 Mixed

Relative Value

50 Mixed

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

− Piotroski F-Score 0–3 — multiple financial weakness signals

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.